Compare Shanghai INT Medical Instruments Co., Ltd. with Similar Stocks
Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
- DEBT-EQUITY RATIO (HY) Highest at 4.21 %
- INTEREST COVERAGE RATIO(Q) Lowest at 4,739.79
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.03 times
2
With ROE of 11.35%, it has a Fair valuation with a 1.74 Price to Book Value
3
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.45%
0%
16.45%
6 Months
6.62%
0%
6.62%
1 Year
26.14%
0%
26.14%
2 Years
24.3%
0%
24.3%
3 Years
29.49%
0%
29.49%
4 Years
115.95%
0%
115.95%
5 Years
5.8%
0%
5.8%
Shanghai INT Medical Instruments Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.51%
EBIT Growth (5y)
13.10%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.38
Tax Ratio
10.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.07%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.74
EV to EBIT
14.33
EV to EBITDA
10.07
EV to Capital Employed
1.91
EV to Sales
3.18
PEG Ratio
0.54
Dividend Yield
NA
ROCE (Latest)
13.29%
ROE (Latest)
11.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
923.70
831.90
11.03%
Operating Profit (PBDIT) excl Other Income
291.40
212.80
36.94%
Interest
2.60
3.50
-25.71%
Exceptional Items
-9.40
2.30
-508.70%
Consolidate Net Profit
206.10
169.30
21.74%
Operating Profit Margin (Excl OI)
221.80%
192.60%
2.92%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 11.03% vs 22.10% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 21.74% vs 8.80% in Dec 2023
About Shanghai INT Medical Instruments Co., Ltd. 
Shanghai INT Medical Instruments Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






